Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes. 2021

Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
University of Kragujevac, Faculty of Medical Sciences, Svetozara Markovica 69, Kragujevac, 34000, Serbia.

BACKGROUND Over the years, transition metal complexes have exhibited significant antimicrobial and antitumor activity. It all started with cisplatin discovery, but due to the large number of side effects it shows, there is a growing need to find a new metal-based compound with higher selectivity and activity on more tumors. OBJECTIVE Two novel trans-palladium(II) complexes with organoselenium compounds as ligands, [Pd(L1)2Cl2] (L1 = 5-(phenylselanylmethyl)-dihydrofuran-2(3H)-one) and [Pd(L2)2Cl2] (L2 = 2- methyl-5-(phenylselanylmethyl)- tetrahydrofuran) were synthesized, in the text referred to as Pd-Se1 and Pd-Se2. Also, a structurally similar trans-palladium(II) complex, [Pd(L3)2Cl2] (L3= 2,2- dimethyl-3-(phenylselanylmethyl)-tetrahydro-2H-pyran) was synthesized according to an already published work and is referred to as Pd-Se3. The interaction of synthesized complexes with DNA and bovine serum albumin was observed. Also, antimicrobial activity and in vitro testing, cell viability, and cytotoxic effects of synthesized ligands and complexes on human epithelial colorectal cancer cell line HCT-116 were studied. Molecular docking simulations were performed to understand better the binding modes of the complexes reported in this paper with DNA and BSA, as well as to comprehend their antimicrobial activity. METHODS The interactions of the synthesized complexes with DNA and bovine serum albumin were done using UV-Vis and emission spectral studies as well as docking studies. Antimicrobial activity was tested by determining the minimum inhibitory concentrations (MIC) and minimum microbicidal concentration (MMC) using the resazurin microdilution plate method. Cytotoxic activity on cancer cells was studied by MTT test. RESULTS The Pd(II) complexes showed a significant binding affinity for calf thymus DNA and bovine serum albumin by UV-Vis and emission spectral studies. The intensity of antimicrobial activity varied with the complexes Pd-Se1 and Pd-Se3, showing significantly higher activity than the corresponding ligand. The most significant activity was shown on Pseudomonas aeruginosa. Under standardized laboratory conditions for in vitro testing, cell viability and cytotoxic effects of synthesized ligands and complexes were studied on human epithelial colorectal cancer cell line HCT-116, where Pd-Se2 showed some significant cytotoxic effects. CONCLUSIONS The newly synthesized complexes have the potential to be further investigated as metallodrugs.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010165 Palladium A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012710 Serum Albumin, Bovine Serum albumin from cows, commonly used in in vitro biological studies. (From Stedman, 25th ed) Fetal Bovine Serum,Fetal Calf Serum,Albumin Bovine,Bovine Albumin,Bovine Serum Albumin,Albumin, Bovine,Albumin, Bovine Serum,Bovine Serum, Fetal,Bovine, Albumin,Calf Serum, Fetal,Serum, Fetal Bovine,Serum, Fetal Calf
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence

Related Publications

Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
November 2010, Journal of inorganic biochemistry,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
April 2021, Molecules (Basel, Switzerland),
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
December 2011, Journal of inorganic biochemistry,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
September 2011, European journal of medicinal chemistry,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
September 2023, Journal of inorganic biochemistry,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
March 2013, Journal of inorganic biochemistry,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
October 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
July 2022, Pharmaceuticals (Basel, Switzerland),
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
January 2014, Bioinorganic chemistry and applications,
Ivana Raković, and Jovana Bogojeski, and Katarina Mladenović, and Angelina Petrović, and Vera Divac, and Kristina Mihailović, and Biljana Popovska Jovicić, and Marina Kostić, and Predrag Canović, and Nevena Milivojević, and Marko Zivanović, and Ivana Radojević
September 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!